At the conclusion of this activity, participants should be able to:
Outline strategies for the treatment of hypertension, hyperlipidemia, ASHD and diabetes, including the use of newer pharmacological agents and lifestyle therapies;
Identify candidates for cardiac resynchronization and wearable versus implantable cardioverter-defibrillator therapies;
Aid gender-specific approaches toward the prevention of cardiovascular health;
Describe current and emerging treatment options for patients with valvular heart disease;
List the latest recommendations for the management of pulmonary embolism, ST and non-ST elevation MI;
Discuss treatment options for the heart failure patient including acute and advanced failure;
Apply knowledge gained in the conference through clinical case review and MOC cases.